Načítá se...
Timing of infliximab and adalimumab initiation despite methotrexate in children with chronic non-infectious anterior uveitis
AIMS: Methotrexate (MTX) is standard treatment in pediatric chronic anterior uveitis (CAU). Addition of tumor necrosis factor-α inhibitors (TNFi) is often needed. We describe the timing and risk factors for TNFi use in children with CAU on MTX. METHODS: In this retrospective study, we reviewed 51 re...
Uloženo v:
| Vydáno v: | Eye (Lond) |
|---|---|
| Hlavní autoři: | , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Nature Publishing Group UK
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6461976/ https://ncbi.nlm.nih.gov/pubmed/30487588 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41433-018-0283-0 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|